SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000886163-01-000008
Filing Date
2001-03-29
Accepted
2001-03-29 00:00:00
Documents
11
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 0001.htm 10-K 398658
2 EXHIBIT 3.5 0002.txt EX-3.5 4994
3 EXHIBIT 10.225 0003.txt EX-10.225 145977
4 EXHIBIT 10.226 0004.txt EX-10.226 28368
5 EXHIBIT 10.227 0005.txt EX-10.227 28424
6 EXHIBIT 10.228 0006.txt EX-10.228 28370
7 EXHIBIT 10.229 0007.txt EX-10.229 28404
8 EXHIBIT 10.230 0008.txt EX-10.230 50960
9 EXHIBIT 21.1 0009.txt EX-21.1 1038
10 EXHIBIT 23.1 0010.txt EX-23.1 634
11 EXHIBIT 23.2 0011.txt EX-23.2 830
  Complete submission text file 0000886163-01-000008.txt   719212
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20720 | Film No.: 1583799
SIC: 2834 Pharmaceutical Preparations